- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Iran on Monday unveiled a new type of antibiotic named 'SinaDoxosome' used for treating various types of abdominal cancers with similar application to Doxorubicin.
The nano drug connects doxil to DNA and prevents the formation of nucleic acid. Studies show that doxil can rapidly diffuse into the cell and stick to chromatin around the nuclei. They also show that the medicine can stop cancerous cells very quickly.
The drug is 100 nanometer in diameter.
The tiny dimension of this drug makes possible its diffusion into the venous tissue of tumors, and it can carry a considerable amount of medicine.
Among the advantages of this drug over the similar non-nanometric drugs, mention can be made of higher solubility, lower toxicity, longer period of staying in the target cell, and more easily diffusion into the cell.
The aforementioned products will be presented in the Fourth Nanotechnology Festival and Exhibition (Iran Nano 2011).
For more information, please click here
Copyright © Fars News AgencyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017
Nanotubes that build themselves April 14th, 2017